Pandemic Innovation
ActiveSaint Louis, MOHealthcare, Biotechnology, Other TravelLast fund filed December 2020
4 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Pandemic Innovation Fund | December 2020 | $25M | $6.1M | 13 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 4 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Mark Bakken | Active | Digital health, Healthcare services, Consumer apps & internet | 27 | 4 |
| Elise Hoffman | Slowing | Consumer apps & internet, Digital health, Healthcare services | 3 | 1 |
| Taha Jangda | Quiet | Digital health, Enterprise software | 3 | 0 |
| William Schmidt | Quiet | Digital health, Medical devices | 7 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Pandemic Innovation’s own portfolio companies, based on 36 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Pandemic Innovation’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| HealthX Ventures | 32 | AGATHOS, AMOpportunities, Amulet, Cancer IQ, CARDIALEN, Carebot Health, Catalyze, DotCom Therapy, ENSODATA, Epharmix, Fifth Eye, FindSpotz, Geno.Me, ImageMoverMD, KeyCare, Kilter, Medsense Health, NarrativeDx, NOVIR, Nurse Disrupted, Peerbridge Health, Prism FM, Ra Medical Systems, Redox, RehabPath, RxLightning, SentiAR, Slot Check, Veda Data Solutions, VedaPointe, Vinyl Health, Wellbe |
| Cultivation Capital Life Sciences | 7 | CARDIALEN, Fifth Eye, ImageMoverMD, NarrativeDx, Ra Medical Systems, SentiAR, VedaPointe |
| LRVHealth | 2 | KeyCare, RxLightning |
| Arboretum Ventures | 1 | Fifth Eye |
| Arthur Ventures | 1 | Catalyze |
| Baird Venture Partners | 1 | Catalyze |
| Battery Ventures | 1 | Redox |
| Emergent Ventures | 1 | Bloom Circle |
| Kairos | 1 | Bloom Circle |
| Lewis & Clark | 1 | Catalyze |
| OCA Ventures | 1 | AMOpportunities |
| Rivervest | 1 | CARDIALEN |
| RRE Ventures | 1 | Redox |
| Silverton Partners | 1 | Prism FM |
| Venture Investors Health | 1 | ENSODATA |
A shared board seat: a company where filings name a Pandemic Innovation partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.